| Literature DB >> 35805706 |
Yeji Yang1,2, Eunbin Ro1,2, Taek-Joo Lee3, Byung-Chul An4, Kwang-Pyo Hong5, Ho-Jun Yun6, Eun-Yeong Park7, Hye-Ryeong Cho8, Suk-Young Yun9, Miok Park10, Young-Jo Yun11, Ai-Ran Lee12, Jeong-Ill Jeon13, Songhie Jung14, Tai-Hyeon Ahn14, Hye-Young Jin14, Kyung Ju Lee15, Kee-Hong Choi1,2.
Abstract
Although many people affected by COVID-19 suffer from some form of psychological distress, access to proper treatment or psychosocial interventions has been limited. This study aimed to examine the feasibility and preliminary effects of a therapeutic gardening program conducted during the COVID-19 pandemic. The program consisted of 30 sessions and was conducted at 10 nationwide sites in Korea from June to November 2021. Mental health and well-being were assessed using the Mental Health Screening Tool for Depressive Disorders, Mental Health Screening Tool for Anxiety Disorders, Engagement in Daily Activity Scale, brief version of World Health Organization Quality of Life, and Mindful Attention Awareness Scale. Cohen's d value was calculated for the effect size, and a multilevel analysis was used to determine the longitudinal effects of therapeutic gardening. The effect sizes for depression, anxiety, daily activities, quality of life, and mindfulness were 0.84, 0.72, 0.61, 0.64, and 0.40, respectively. Multilevel analyses showed that all five mental health variables improved significantly over time as the therapeutic gardening program progressed. Therapeutic gardening is promising and applicable as a nature-based intervention to improve the mental health of individuals experiencing psychological distress especially in the COVID-19 pandemic.Entities:
Keywords: COVID-19; gardening; mental health; nature-based intervention; psychosocial intervention; public health; well-being
Mesh:
Year: 2022 PMID: 35805706 PMCID: PMC9266122 DOI: 10.3390/ijerph19138046
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Participants Characteristics (N = 111).
| Variables | |
|---|---|
|
| |
| Male | 23 (20.7%) |
| Female | 88 (79.3%) |
|
| |
| 18–30 | 17 (15.3%) |
| 31–40 | 8 (7.2%) |
| 41–50 | 18 (16.2%) |
| 50–64 | 25 (22.5%) |
| ≥65 | 43 (38.7%) |
|
| |
| None | 52 (46.8%) |
| Neurodevelopmental Disorder | 15 (13.5%) |
| Neurocognitive Disorder | 14 (12.6%) |
| Depressive Disorder | 13 (11.7%) |
| Schizophrenia | 12 (10.8%) |
| Bipolar Spectrum Disorder | 4 (3.6%) |
| Anxiety Disorder | 1 (0.9%) |
|
| |
| No Education | 1 (0.9%) |
| Primary school | 8 (7.2%) |
| Secondary school | 18 (16.2%) |
| University bachelor degree | 53 (47.7%) |
| Higher Education | 8 (7.2%) |
| Unknown | 23 (20.7%) |
Note: N = number of participants.
Effect sizes (Cohen’d), the result of multilevel analysis, and mean scores of five mental health measures.
| Cohen’s | Multilevel Analysis | Mean Scores | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Effects | SE | df | t | T1 | T2 | T3 | T4 | T5 | T6 | T7 | T8 | ||||
| 0.84 | Mean | 18.2 | 13.7 | 12.4 | 12.8 | 11.5 | 11.3 | 10.2 | 9.55 | ||||||
| Intercept | 12.580 | 1.503 | 638 | 8.369 | <0.0001 | (SD) | (8.91) | (10.4) | (9.72) | (11.5) | (9.89) | (10.8) | (9.39) | (9.42) | |
| Time | −0.998 | 0.230 | 638 | −4.340 | 0.0014 * | N | 110 | 81 | 98 | 83 | 102 | 72 | 99 | 105 | |
| 0.72 | Mean | 16.2 | 13.7 | 11.2 | 11.8 | 11.4 | 11.6 | 10.4 | 8.98 | ||||||
| Intercept | 11.615 | 1.554 | 639 | 7.472 | <0.0001 | (SD) | (9.42) | (10.4) | (9.68) | (10.5) | (10.5) | (10.2) | (9.83) | (9.17) | |
| Time | −0.741 | 0.166 | 639 | −4.469 | 0.0033 * | N | 111 | 81 | 98 | 83 | 102 | 72 | 99 | 105 | |
| 0.61 | Mean | 15.6 | 15.9 | 17.0 | 16.7 | 16.8 | 15.9 | 17.0 | 18.1 | ||||||
| Intercept | 16.966 | 0.641 | 638 | 26.473 | <0.0001 | (SD) | (3.81) | (3.05) | (4.01) | (4.10) | (4.52) | (3.23) | (4.37) | (4.32) | |
| Time | 0.236 | 0.081 | 638 | 2.911 | 0.0037 * | N | 110 | 81 | 98 | 83 | 102 | 72 | 99 | 105 | |
| 0.64 | Mean | 76.4 | 87.2 | ||||||||||||
| Intercept | 82.205 | 2.330 | 91 | 35.278 | <0.0001 | (SD) | (14.2) | (18.1) | |||||||
| Time | 9.710 | 2.604 | 91 | 3.729 | 0.0003 * | N | 98 | 92 | |||||||
| 0.40 | Mean | 55.9 | 62.7 | ||||||||||||
| Intercept | 58.950 | 1.695 | 98 | 34.789 | <0.0001 | (SD) | (15.4) | (15.4) | |||||||
| Time | 6.296 | 2.106 | 98 | 2.990 | 0.0035 * | N | 104 | 99 | |||||||
Note: SE = Standard Error. df = degree of freedom. t = t-value. * p-value < 0.01. The interval between time points is 2 weeks (4 sessions). WHOQOL-BREF and MAAS were only assessed at pre- and post-test. T1 = Pre-test, T8 = Post-test; MHS:D—Mental Health Screening Tool for Depressive disorders; MHS:A—Mental Health Screening Tool for Anxiety disorders; EDAS—Engagement in Daily Activity Scale; WHOQOL-BREF—Brief version of WHO Quality of Life; MAAS—Mindful Attention Awareness Scale.
Figure 1Significant moderating effect of gender, age, and presence of mental disorder for Mental Health Screening Tool for Depressive disorders and Brief version of WHO Quality of Life. (a) Moderating effect of gender on depression (p = 0.0427); (b) moderating effect of age on depression (p = 0.0042); (c) moderating effect of presence of mental disorder on depression (p = 0.0661); (d) moderating effect of presence of mental disorder on quality of life (p = 0.0008). The interval between time points is 2 weeks (4 sessions). T1 = Pre-test, T8 = Post-test. Shaded areas represent the 95% confidence intervals.